Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder-Reference-Cited by-同舟云学术

Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder

Published:2015-07-07 Issue:1 Volume:9 Page:38-45
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:Lower Urinary Tract Symptoms

Author:

YAMAGUCHI Osamu¹,IKEDA Yasushi²,OHKAWA Sumito²

Affiliation:

1. Division of Bioengineering and LUTD Research; Nihon University, School of Engineering; Koriyama Japan

2. Astellas Pharma Inc; Tokyo Japan

Funder

Astellas

Kissei

Kyorin

Publisher

Wiley

Subject

Urology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/luts.12107/fullpdf

Reference27 articles.

1. Clinical guidelines for overactive bladder;Yamaguchi;Int J Urol,2009

2. Director of the Evaluation and Licensing Division PaFSB, Japanese Ministry of Health, Labour and Welfare Guidelines for Clinical Evaluation of Therapeutics for Overactive Bladder 2006

3. Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment;Brubaker;Urology,2006

4. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study;Coyne;BJU Int,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The choice of therapeutic agent in female overactive bladder patients in real-world practice;Archivio Italiano di Urologia e Andrologia;2022-12-27

2. Mirabegron in the Management of Overactive Bladder Syndrome;International Journal of Women's Health;2022-09

3. Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations;Research and Reports in Urology;2022-04

4. Diagnosis and management of overactive bladder: A review;Journal of Obstetrics and Gynaecology Research;2021-02-16

5. Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia;Current Urology Reports;2021-01